Baxter’s Renal business is committed to addressing the individual needs of end-stage renal disease (ESRD) patients by providing access to innovative products, therapies, services and support designed to improve their health-related, quality-of-life. Baxter has over 125 collective years of experience in renal care. The company continues to invest in the business, reflecting its commitment to advancing and simplifying dialysis, expanding capacity for growing demand and investing in R&D to drive innovation.

Baxter Healthcare Pty Ltd
Tel: 1800 BAXTER (1800 229 837)

Baxter Healthcare Limited
New Zealand
Tel: 0800 BAXTER (0800 229 837)



Dialysis Australia is a respected and experienced provider of home-based dialysis services.  As an enabler of in-home dialysis care, Dialysis Australia is changing the landscape for people living with Chronic Kidney Disease by allowing a greater number of patients to dialyse in the comfort of their own home.

The Assisted Home Haemodialysis (AHHD) model of care – where an experienced nurse can administer full dialysis treatment or offer cannulation support, was pioneered by Dialysis Australia in bringing hospital care into patients’ own homes, providing them with choice and flexibility in where they receive their care. The benefits of receiving dialysis at home include:

  • Choice in treatment times
  • Improved quality of life
  • Elimination of travel costs
  • Improved morbidity and mortality

Providing excellence in Healthcare founded on the principles of quality of care, care for the patient, integrity of staff and respect for all, Dialysis Australia delivers “Care with compassion and commitment” making us your home dialysis experts.



Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.

Our belief–and the core of our strategy–is that innovative, highly differentiated medicines that provide large clinical benefits in addressing serious diseases are medicines that will not only help patients, but also will help reduce the social and economic burden of disease.

Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people’s lives. A biotechnology innovator since 1980, Amgen has grown to be one of the world’s leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.



Otsuka is a global company with an international network of 189 companies, 47,000 employees, 47 affiliated research institutes and 171 manufacturing sites. Otsuka operates in more than 80 countries and regions across Asia-Pacific, America, Europe, and the Middle East. The people at Otsuka are dedicated to creating new products for better health worldwide.

Underpinning these words is our commitment to:

  • Creating unique and innovative products
  • Improving health and well-being
  • Contributing to the lives of people worldwide



Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives.
Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Twentynine medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines.

Founded in 1896, the Roche Group is headquartered in Basel, Switzerland, and is active in over 100 countries. In 2016 Roche employed more than 94,000 people worldwide and invested CHF 9.9 billion in research and development, including almost AUD 37 million in pharmaceuticals in Australia. Roche has been recognised as the Group Leader in sustainability within the Pharmaceuticals, Biotechnology & Life Sciences Industry eight years in a row by the Dow Jones Sustainability Indices.

Roche’s pharmaceutical division in Australia is dedicated to the clinical development, registration, sales, marketing and distribution of innovative pharmaceutical medicines. Australian patients have access to about 40 Roche medicines, and the company is the leading provider of cancer medicines in Australia by sales.



Fresenius Medical Care is the world’s leading provider of products and services for people with chronic kidney failure.
Our mission is simple – To create a future worth living for patients worldwide, every day. Around 3.4 million patients with this disease worldwide regularly undergo dialysis treatment and every 0.6 seconds Fresenius Medical Care provide a dialysis treatment somewhere on the globe.
We care for more than 336,000 patients in our global network of over 3,900 dialysis clinics. At the same time, we operate 42 production sites on all continents, providing dialysis products such as dialysis machines, dialyzers and related disposables. Fresenius Medical Care has been developing and producing dialysis products for more than four decades.

The Fresenius Medical Care family employs around 112,000 people across 50 countries.
Locally, our ANZ team supports dialysis products and services to public and private hospitals for patients with chronic or acute kidney failure. We are also one of the largest private providers, caring for patients across a network of 24 dialysis clinics as well as home therapies programs.
Our global and local strategy is geared toward sustainable growth. We aim to continuously improve the quality of life of patients with kidney disease by offering innovative products and treatment concepts of the highest quality.


AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three therapy areas – Oncology, Cardiovascular, Renal & Metabolism and Respiratory. The Company also is selectively active in the areas of autoimmunity, neuroscience and infection. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide.



Vifor Pharma Australia is a pharmaceutical company that specialises in innovative and patient-focused treatments for chronic kidney disease and iron deficiency. We are a leader in the treatment of iron deficiency and iron deficiency anaemia where our products treat over half a million Australia and New Zealand patients annually.


Fist Assist Devices is a Silicon Valley, CA USA medical device company with a new patented technology for arm vein dilation before and after fistula surgery. We are the ideal device for the growing Home hemodialysis market. Our device is now CE Mark approved for sale in Australia via our global partner  Amazon.


As a global leader in medical technology, services and solutions, Medtronic improves the lives and health of millions of people each year. We use our deep clinical, therapeutic, and economic expertise to address the complex challenges faced by healthcare systems today. Let’s take healthcare Further, Together.



The ASM is hosted by Australian and New Zealand Society of Nephrology.

The aims of the Society are to promote and support the study of the kidney and urinary tract in health and disease, and to ensure the highest professional standards for the practice of nephrology in Australia and New Zealand.

Conference Managers

Please contact the team at Conference Design with any questions regarding the Annual Scientific Meeting

© 2015 - 2016 Conference Design Pty Ltd